Brief: Isofol Medical Presents Gene Expression Results From Completed Phase I/IIa ISO-CC-005 Study

Isofol Medical AB (publ)

15/01/2021 13:20

Jan 15 (Reuters) - Isofol Medical AB (publ)  ISOFOL.ST :
    * PRESENTS GENE EXPRESSION RESULTS FROM COMPLETED PHASE
I/IIA
ISO-CC-005 STUDY AT ASCO-GI 2021
    * RESULT FROM PHASE I/IIA ISO-CC-005-STUDY WHICH SHOWS
CORRELATION
BETWEEN CLINICAL BENEFIT AND GENE EXPRESSION IN PATIENTS WITH
CANCER TREATED WITH 5-FU-BASED CHEMOTHERAPY IN COMBINATION WITH
ARFOLITIXORIN

Source text for Eikon:  ID:nWkr1BDGfB 
Further company coverage:  ISOFOL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))